An "ON'', Switch Mechanism Modulating Expression of IL-l8 and Osr2 to Enhance the Effcacy of CAR-T Therapy in Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) remains difficult to treat, and its fibrotic, immunosuppressive tumor microenvironment are major obstacles to chimeric antigen receptor (CAR)-T cell therapy due to the T cell exhaustion and reduction in T cell activation. This proposal asks whether inducible interleukin-18 (IL-18) and biomechanical checkpoint Osr2 knockdown can improve the efficacy of mesothelin-targeted CAR-T cells in PDAC. The proposed CAR-T cell combined split CAR as a "ON" switch which can be integrated by lenalidomide, and inserted with inducible IL-18 cassette and Osr2 shRNA cassette. The drug-dependent CAR provides a method to control the T cell expression which can help reduce the toxicity. Furthermore, IL-18 is intended to support immune activation, while Osr2 shRNA is aimed to knockdown Osr2, in turn, reduce the exhaustion of CAR-T cells associated with the tumor environment. We proposed experiments in different treatments of CAR-T cells including combining a CAR-T cell control group without any modification, CAR-T cell with both modifications, CAR-T cell with only single modification lacking either cassettes, a T-cell group, a mesothelin-negative group, and a vehicle group. By comparing the tumor burden, survival, CAR-T infiltration, exhaustion markers, and toxicity, the results will prove whether "ON" switched CAR-T cells with inducible IL-18 and Osr2 shRNA cassettes can improve the tumor control.

Authors

Institutions

Publication Details

Journal
Theoretical and Natural Science
Published
2026-11-17
DOI
https://doi.org/10.54254/2753-8818/2026.39183
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

An "ON'', Switch Mechanism Modulating Expression of IL-l8 and Osr2 to Enhance the Effcacy of CAR-T Therapy in Pancreatic Ductal Adenocarcinoma

子涵 周, Yuhan Xu, Wanqi Luo, Henry Liu
4 links
Theoretical and Natural Science
CAR-T cell therapy research
article

An "ON'', Switch Mechanism Modulating Expression of IL-l8 and Osr2 to Enhance the Effcacy of CAR-T Therapy in Pancreatic Ductal Adenocarcinoma

子涵 周, Yuhan Xu, Wanqi Luo, Henry Liu
article en

Abstract

Pancreatic ductal adenocarcinoma (PDAC) remains difficult to treat, and its fibrotic, immunosuppressive tumor microenvironment are major obstacles to chimeric antigen receptor (CAR)-T cell therapy due to the T cell exhaustion and reduction in T cell activation. This proposal asks whether inducible interleukin-18 (IL-18) and biomechanical checkpoint Osr2 knockdown can improve the efficacy of mesothelin-targeted CAR-T cells in PDAC. The proposed CAR-T cell combined split CAR as a "ON" switch which can be integrated by lenalidomide, and inserted with inducible IL-18 cassette and Osr2 shRNA cassette. The drug-dependent CAR provides a method to control the T cell expression which can help reduce the toxicity. Furthermore, IL-18 is intended to support immune activation, while Osr2 shRNA is aimed to knockdown Osr2, in turn, reduce the exhaustion of CAR-T cells associated with the tumor environment. We proposed experiments in different treatments of CAR-T cells including combining a CAR-T cell control group without any modification, CAR-T cell with both modifications, CAR-T cell with only single modification lacking either cassettes, a T-cell group, a mesothelin-negative group, and a vehicle group. By comparing the tumor burden, survival, CAR-T infiltration, exhaustion markers, and toxicity, the results will prove whether "ON" switched CAR-T cells with inducible IL-18 and Osr2 shRNA cassettes can improve the tumor control.

Theoretical and Natural ScienceVol. 203(1)
United World College of South East Asia (SG), Mater Dei High School (US)
Yuhan
Good health and well-being
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon